Literature DB >> 7717599

Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue.

E Roggero1, E Zucca, G Pinotti, A Pascarella, C Capella, A Savio, E Pedrinis, A Paterlini, A Venco, F Cavalli.   

Abstract

OBJECTIVE: To determine the effect of eradicating Helicobacter pylori infection on the course of low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
DESIGN: Prospective cohort study.
SETTING: University internal medicine clinics, a referral oncology center in southern Switzerland, and a gastroenterology referral center in northern Italy. PATIENTS: 26 patients with localized primary low-grade gastric MALT lymphoma. INTERVENTION: Treatment for H. pylori infection (bismuth or omeprazole or both, amoxicillin, and metronidazole for 14 days). MAIN OUTCOME MEASURES: Endoscopic biopsy specimens of the gastric mucosa were obtained every 3 to 6 months after treatment for H. pylori infection.
RESULTS: Helicobacter pylori was completely eradicated in 25 of 26 patients, but 4 patients needed second-line antibiotic treatment to eradicate the microorganism. Disappearance or almost total regression of the lymphomatous tissue was observed in 15 of the 25 evaluable patients (60%; CI, 39% to 79%); however, disappearance or almost total regression was evident in the first biopsy specimen after treatment for H. pylori infection in only 8 of the 15 patients.
CONCLUSIONS: Our study confirms recent anecdotal reports of regression of gastric MALT lymphoma after eradication of H. pylori and indicates that the growth of these extranodal lymphomas may depend on H. pylori.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717599     DOI: 10.7326/0003-4819-122-10-199505150-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  57 in total

1.  MALT Lymphoma of the Gastric Remnant After Roux-en-Y Gastric Bypass.

Authors:  Ahmed Jawad; Allan H Bar; Demetri Merianos; Jing Zhou
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 2.  Dual roles for immunity in gastrointestinal cancers.

Authors:  Cristina Ferrone; Glenn Dranoff
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

3.  Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue.

Authors:  Antoine de Mascarel; Agnès Ruskone-Fourmestraux; Anne Lavergne-Slove; Francis Megraud; Pierre Dubus; Jean-Philippe Merlio
Journal:  Virchows Arch       Date:  2005-03-02       Impact factor: 4.064

4.  Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma.

Authors:  R Marasca; P Vaccari; M Luppi; P Zucchini; I Castelli; P Barozzi; A Cuoghi; G Torelli
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.

Authors:  A Morgner; S Miehlke; M Stolte; A Neubauer; B Alpen; C Thiede; H Klann; F X Hierlmeier; C Ell; G Ehninger; E Bayerdörffer
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

6.  Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.

Authors:  W Fischbach; M-E Goebeler-Kolve; B Dragosics; A Greiner; M Stolte
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

7.  Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice.

Authors:  A Enno; J O'Rourke; S Braye; R Howlett; A Lee
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

8.  Complete remission of gastric Burkitt's lymphoma after eradication of Helicobacter pylori.

Authors:  Isabelle Baumgaertner; Christiane Copie-Bergman; Michael Levy; Corinne Haioun; Antoine Charachon; Maryse Baia; Iradj Sobhani; Jean-Charles Delchier
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

Review 9.  Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Jeong Bae Park; Ja Seol Koo
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

10.  Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.

Authors:  Monika Joshi; Hassan Sheikh; Kamal Abbi; Sarah Long; Kamal Sharma; Mark Tulchinsky; Elliot Epner
Journal:  Ther Adv Hematol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.